Clinical trial
A Multi-Center, Randomized, Double-Blind, Parallel, Phase III Clinical Trial to Evaluate the Efficacy and Safety of UI022/UI023
NCT07600385 is registered in ClinicalTrials.gov with Korea United Pharm. Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multi-Center, Randomized, Double-Blind, Parallel, Phase III Clinical Trial to Evaluate the Efficacy and Safety of UI022/UI023
- Lead sponsor
- Korea United Pharm. Inc.
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- March 12, 2019
- Completion date
- May 3, 2022
- Enrollment
- 260 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.